Literature DB >> 6252166

Antibacterial activity of cefotaxime and other newer cephalosporins (in vitro and in vivo).

E Schrinner, M Limbert, L Penasse, A Lutz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6252166     DOI： 10.1093/jac/6.suppl_a.25

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  16 in total

1.  Third generation cephalosporins in the parenteral to oral switch.

Authors:  D Rimmer
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

Review 2.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 3.  Antibiotics in the treatment of biliary infection.

Authors:  J S Dooley; J M Hamilton-Miller; W Brumfitt; S Sherlock
Journal:  Gut       Date:  1984-09       Impact factor: 23.059

4.  Cefotaxime and desacetyl cefotaxime in human bile.

Authors:  F Kees; E Strehl; P Dominiak; H Grobecker; K Seeger; G Seidel; B Neuhaus; L Safrany
Journal:  Infection       Date:  1983 Mar-Apr       Impact factor: 3.553

5.  The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination.

Authors:  R M Ings; D S Reeves; L O White; R P Bax; M J Bywater; H A Holt
Journal:  J Pharmacokinet Biopharm       Date:  1985-04

6.  In vitro activity of cefotaxime against clinically significant pathogens.

Authors:  S Nakashio; M Nakamura
Journal:  Drugs       Date:  1988       Impact factor: 9.546

7.  Ceftriaxone: in vitro activity against 410 bacterial isolates compared with cefotaxime.

Authors:  A Digranes; E Benonisen; W L Dibb
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

8.  Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats.

Authors:  I A Bakker-Woudenberg; J C van den Berg; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

9.  Population Pharmacokinetics of Cefotaxime and Dosage Recommendations in Children with Sickle Cell Disease.

Authors:  Elsa Maksoud; Berengere Koehl; Aude Facchin; Phuong Ha; Wei Zhao; Florentia Kaguelidou; Malika Benkerrou; Patricia Mariani; Albert Faye; Mathie Lorrot; Evelyne Jacqz-Aigrain
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

10.  The cooperation of cefotaxime and desacetyl-cefotaxime with respect to antibacterial activity and beta-lactamase stability.

Authors:  M Limbert; G Seibert; E Schrinner
Journal:  Infection       Date:  1982       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.